WallStSmart
CRIS

Curis Inc

NASDAQ: CRIS · HEALTHCARE · BIOTECHNOLOGY

$0.60
+6.88% today

Updated 2026-04-30

Market cap
$23.79M
P/E ratio
P/S ratio
2.52x
EPS (TTM)
$-0.58
Dividend yield
52W range
$0 – $3
Volume
0.5M

WallStSmart proprietary scores

20
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F
5.0
Quality
C+
2.0
Profitability
F
4.0
Valuation
C
4/9
Piotroski F-Score
Moderate
-44.3
Altman Z-Score
Distress
Industry rank
View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target
$14.00
+2233.33%
12-Month target
Intrinsic (DCF)
$0.91
Margin of safety
-16.48%
1 Strong Buy3 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Debt/equity -2.08x — low leverage
Risks
- Altman Z -44.25 — distress zone
- Thin margins at -80.30%
- Negative free cash flow $-6.37M
- Revenue declining -66.00% QoQ
- 16.48% above intrinsic value

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$10.16M$10.02M$10.91M$9.44M$9.44M
Net income$-60.32M$-47.41M$-43.39M$-7.58M$19.36M
EPS$-0.58
Free cash flow$-54.75M$-38.85M$-39.56M$-27.20M$-6.37M
Profit margin-593.62%-473.04%-397.77%-80.29%-80.30%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
CRIS$23.79M202.72.04.05.0-16.48%Avoid
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$336.47B545.35.57.34.8+42.09%Buy
AZN$287.11B646.78.05.35.0+4.07%Buy

Smart narrative

Curis Inc trades at $0.60. Our Smart Value Score of 20/100 indicates the stock is weak. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of -44.25, it sits in the distress. TTM revenue stands at $9.44M. with profit margins at -80.30%. Our DCF model estimates intrinsic value at $0.91.

Frequently asked questions

What is Curis Inc's stock price?
Curis Inc (CRIS) trades at $0.60.
Is Curis Inc overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell). DCF value $0.91.
What is the price target of Curis Inc (CRIS)?
The analyst target price is $14.00, representing +2233.3% upside from the current price of $0.60.
What is the intrinsic value of Curis Inc (CRIS)?
Based on our DCF model, intrinsic value is $0.91, a -16.5% margin of safety versus $0.60.
What is Curis Inc's revenue?
TTM revenue is $9.44M.
Piotroski F-Score?
4/9 — moderate financial health.
Altman Z-Score?
-44.25 — distress.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio2.52x
ROE-2,951.00%
Beta3.14
50D MA$0.81
200D MA$1.26
Shares out0.04B
Float0.03B
Short ratio
Avg volume0.5M

Performance

1 week
1 month
3 months
YTD
1 year
3 years
5 years